1. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012; 64:3061–7.
Article
2. Kottahachchi D, Topliss DJ. Immunoglobulin G4-related thyroid diseases. Eur Thyroid J. 2016; 5:231–9.
Article
3. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344:732–8.
Article
4. Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006; 16:335–40.
Article
5. Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013; 19:35–41.
Article
6. Geyer JT, Ferry JA, Harris NL, Stone JH, Zukerberg LR, Lauwers GY, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010; 34:202–10.
7. Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010; 62:1312–8.
Article
8. Rotondi M, Carbone A, Coperchini F, Fonte R, Chiovato L. Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol. 2019; 180:R175–83.
Article
9. Komatsu K, Hamano H, Ochi Y, Takayama M, Muraki T, Yoshizawa K, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci. 2005; 50:1052–7.
Article
10. Sah RP, Chari ST. Clinical hypothyroidism in autoimmune pancreatitis. Pancreas. 2010; 39:1114–6.
Article
11. Li Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, Mori I, et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol Int. 2009; 59:636–41.
Article
12. Topliss DJ. Clinical update in aspects of the management of autoimmune thyroid diseases. Endocrinol Metab (Seoul). 2016; 31:493–9.
Article
13. Li Y, Zhou G, Ozaki T, Nishihara E, Matsuzuka F, Bai Y, et al. Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012; 25:1086–97.
Article
14. Zhao Z, Lee YJ, Zheng S, Khor LY, Lim KH. IgG4-related disease of the thyroid gland requiring emergent total thyroidectomy: a case report. Head Neck Pathol. 2019; 13:523–7.
Article
15. Jokisch F, Kleinlein I, Haller B, Seehaus T, Fuerst H, Kremer M. A small subgroup of Hashimoto’s thyroiditis is associated with IgG4-related disease. Virchows Arch. 2016; 468:321–7.
Article
16. Zhang J, Zhao L, Gao Y, Liu M, Li T, Huang Y, et al. A classification of Hashimoto’s thyroiditis based on immunohistochemistry for IgG4 and IgG. Thyroid. 2014; 24:364–70.
Article
17. Lee IS, Lee JU, Lee KJ, Jang YS, Lee JM, Kim HS. Painful immunoglobulin G4-related thyroiditis treated by total thyroidectomy. Korean J Intern Med. 2016; 31:399–402.
Article
18. Kim CS, Lee SJ, Park JS, Nam JY, Kim DM, Ahn CW, et al. A case of Riedel’s thyroiditis in a patient with a history of subacute thyroiditis. J Korean Soc Endocrinol. 2003; 18:414–9.
19. Lee DY, Moon JS, Kim GE, Kim HK, Kang HC. Riedel thyroiditis in a patient with graves disease. Endocrinol Metab (Seoul). 2013; 28:138–43.
Article
20. Song E, Oh HS, Jeon MJ, Chung KW, Hong SJ, Ryu JS, et al. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma. Int J Cancer. 2019; 144:1414–20.
Article
21. Choi EK, Kim MH, Lee TY, Kwon S, Oh HC, Hwang CY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas. 2007; 35:156–61.
22. Takeshima K, Li Y, Kakudo K, Hirokawa M, Nishihara E, Shimatsu A, et al. Proposal of diagnostic criteria for IgG4-related thyroid disease. Endocr J. 2021; 68:1–6.
Article
23. Li Y, Inomata K, Nishihara E, Kakudo K. IgG4 thyroiditis in the Asian population. Gland Surg. 2020; 9:1838–46.
Article
24. Yu Y, Liu J, Yu N, Zhang Y, Zhang S, Li T, et al. IgG4 immunohistochemistry in Riedel’s thyroiditis and the recommended criteria for diagnosis: a case series and literature review. Clin Endocrinol (Oxf). 2021; 94:851–7.
Article
25. Olejarz M, Szczepanek-Parulska E, Dadej D, Sawicka-Gutaj N, Domin R, Ruchala M. IgG4 as a biomarker in Graves’ orbitopathy. Mediators Inflamm. 2021; 2021:5590471.
Article
26. Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K. Distinct clinical, serological, and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010; 95:1309–17.
Article
27. Kawashima ST, Tagami T, Nakao K, Nanba K, Tamanaha T, Usui T, et al. Serum levels of IgG and IgG4 in Hashimoto thyroiditis. Endocrine. 2014; 45:236–43.
Article
28. Takeshima K, Ariyasu H, Inaba H, Inagaki Y, Yamaoka H, Furukawa Y, et al. Distribution of serum immunoglobulin G4 levels in Hashimoto’s thyroiditis and clinical features of Hashimoto’s thyroiditis with elevated serum immunoglobulin G4 levels. Endocr J. 2015; 62:711–7.
Article
29. Raess PW, Habashi A, El Rassi E, Milas M, Sauer DA, Troxell ML. Overlapping morphologic and immunohistochemical features of Hashimoto thyroiditis and IgG4-related thyroid disease. Endocr Pathol. 2015; 26:170–7.
Article
30. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22:21–30.
Article
31. Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto’s thyroiditis. Hum Pathol. 1974; 5:161–70.
Article
32. Deshpande V, Huck A, Ooi E, Stone JH, Faquin WC, Nielsen GP. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol. 2012; 65:725–8.
Article
33. Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc. 1985; 60:836–43.
Article
34. Pusztaszeri M, Triponez F, Pache JC, Bongiovanni M. Riedel’s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid. 2012; 22:964–8.
Article
35. Cameselle-Teijeiro J, Ladra MJ, Abdulkader I, Eloy C, Soares P, Barreiro F, et al. Increased lymphangiogenesis in Riedel thyroiditis (immunoglobulin G4-related thyroid disease). Virchows Arch. 2014; 465:359–64.
Article
36. Takeshima K, Inaba H, Ariyasu H, Furukawa Y, Doi A, Nishi M, et al. Clinicopathological features of Riedel’s thyroiditis associated with IgG4-related disease in Japan. Endocr J. 2015; 62:725–31.
Article
37. Stan MN, Sonawane V, Sebo TJ, Thapa P, Bahn RS. Riedel’s thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf). 2017; 86:425–30.
Article
38. Simoes CA, Tavares MR, Andrade NM, Uehara TM, Dedivitis RA, Cernea CR. Does the intensity of IGG4 immunostaining have a correlation with the clinical presentation of Riedel’s thyroiditis? Case Rep Endocrinol. 2018; 2018:4101323.
39. Falhammar H, Juhlin CC, Barner C, Catrina SB, Karefylakis C, Calissendorff J. Riedel’s thyroiditis: clinical presentation, treatment and outcomes. Endocrine. 2018; 60:185–92.
Article
40. Blanco VM, Paez CA, Victoria AM, Arango LG, Arrunategui AM, Escobar J, et al. Riedel’s thyroiditis: report of two cases and literature review. Case Rep Endocrinol. 2019; 2019:5130106.
Article
41. Hennessey JV. Clinical review: Riedel’s thyroiditis: a clinical review. J Clin Endocrinol Metab. 2011; 96:3031–41.
42. Nishihara E, Hirokawa M, Takamura Y, Ito M, Nakamura H, Amino N, et al. Immunoglobulin G4 thyroiditis in a Graves’ disease patient with a large goiter developing hypothyroidism. Thyroid. 2013; 23:1496–7.
Article
43. Takeshima K, Inaba H, Furukawa Y, Nishi M, Yamaoka H, Miyamoto W, et al. Elevated serum immunoglobulin G4 levels in patients with Graves’ disease and their clinical implications. Thyroid. 2014; 24:736–43.
Article
44. Bozkirli E, Bakiner OS, Ersozlu Bozkirli ED, Eksi Haydardedeoglu F, Sizmaz S, Torun AI, et al. Serum immunoglobulin G4 levels are elevated in patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 2015; 83:962–7.
Article
45. Sy A, Silkiss RZ. Serum total IgG and IgG4 levels in thyroid eye disease. Int Med Case Rep J. 2016; 9:325–8.
Article
46. Torimoto K, Okada Y, Kurozumi A, Narisawa M, Arao T, Tanaka Y. Clinical features of patients with Basedow’s disease and high serum IgG4 levels. Intern Med. 2017; 56:1009–13.
Article
47. Martin CS, Sirbu AE, Betivoiu MA, Florea S, Barbu CG, Fica SV. Serum immunoglobulin G4 levels and Graves’ disease phenotype. Endocrine. 2017; 55:478–84.
Article
48. Yu SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, et al. Clinical implications of immunoglobulin G4 to Graves’ ophthalmopathy. Thyroid. 2017; 27:1185–93.
Article
49. Hiratsuka I, Yamada H, Itoh M, Shibata M, Takayanagi T, Makino M, et al. Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves’ disease. Exp Clin Endocrinol Diabetes. 2020; 128:119–24.
Article
50. Luo B, Yuan X, Wang W, Zhang J, Liu R, Hu W, et al. Ocular manifestations and clinical implications of serum immunoglobulin G4 levels in Graves’ ophthalmopathy patients. Ocul Immunol Inflamm. 2020; Oct. 15. [Epub].
https://doi.org/10.1080/09273948.2020.1826537.
Article